Pliant Therapeutics (PLRX) Earnings Date & Reports

A.I. Advisor

published Earnings

PLRX is expected to report earnings to rise 4.72% to -96 cents per share on November 05

Pliant Therapeutics PLRX Stock Earnings Reports

Q3'24

Est.

$-0.96

Q2'24

Missed

by $0.07

Q1'24

Missed

by $0.01

Q4'23

Beat

by $0.12

Q3'23

Beat

by $0.08

The last earnings report on August 07 showed earnings per share of -92 cents, missing the estimate of -85 cents. With 216.05K shares outstanding, the current market capitalization sits at 687.66M.

View a ticker or compare two or three

Compare

PLRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PLRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for PLRX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company which engages in the business of developing and commercializing novel therapies for fibrotic diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

260 Littlefield Avenue

Phone

+1 650 481-6770

Employees

158

Web

https://www.pliantrx.com